2021 annual financial data
Pliant Therapeutics 2021 Operating cash flow margin
Direct answer
Operating cash flow margin was -996.34%.
Operating income was -19,986,000 USD and net income was -17,907,000 USD.
Operating cash flow was -75,443,000 USD.
Get free Pliant Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 7,572,000 USD
- Operating income
- -19,986,000 USD
- Net income
- -17,907,000 USD
- Operating cash flow
- -75,443,000 USD